Home
Consulting Services
Prior Activities
Contact Us
Resume Donald L. MacKeen, Ph.D
Bibliography
New Drug Delivery
e-mail me

PRIOR ACTIVITIES


The following lists various projects in whlich MCI was completelly or partially responsible for obtaining FDA approval, either  for marketing or for clinical investigation.


Ophthalmic products




  • First non-thermal contact lens disinfecting solutions


  • Novel polymer dry eye solution


  • First commercially available punctum plug


  • Numerous contact lens studies: developmental and clinical investigations of hydrophilic soft and high DK RGP lenses


  • Lactoplate ( lactoferrin assaly of lacrimal fluid)


  • Sulfur hexaflluoride and perfluoropropane for treatment of retinal detachments


  • Initial clinical studies of silicone oil for retinal detachments


  • Initial formulations and submission for the use of cyclsporine and the treament of dry eye conditions


  • Clinical study of calcium carbonate ointment for the supracutaneous treatment of dry eyes


  • First tandem scanning confocal microscope for clinical use


  • Dye lasers for ophthalmic use


  • Clinical linvestigation of cultured corneal endothelial  cells for DLEK procedures.

Non-Ophthalmic products




  • Critical care device for the non-invasive measurement of gastric blood flow


  • Clinical investigation of sthe first 60Hz magnetic device for the  treatment of muscle pain